PATENT CLAIM ANALYSIS

Application Number: 16017447
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "558000"]

Abstract:
Compositions including an odd chain fatty acid, and salts and derivatives thereof, and methods for metabolic syndrome treatment and prophylaxis are provided, including compositions and methods for treating diabetes, obesity, hyperferritinemia, elevated insulin, glucose intolerance, dyslipidemia and related conditions. Methods for the diagnosis and monitoring of metabolic syndrome are also provided.

Claim (Index 1):
A pharmaceutical composition comprising:\n one or more odd chain fatty acids or pharmaceutically acceptable salts thereof; a pharmaceutically acceptable carrier; wherein at least one of the one or more odd chain fatty acids is selected from the group consisting of C15:0 (pentadecanoic acid) and C17:0 (heptadecanoic acid); and, wherein the composition is in a unit dosage for the treatment of conditions selected from the group consisting of type 2 diabetes, elevated fasting plasma glucose, elevated serum triglycerides, and hyperferritinemia.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.5641
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15030031', '15393799', '15393771', '14980695', '14980304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7763398163127702
- 35 USC 102 Novelty (BERT): 0.6023186724887853
- Combined Prediction Score: 0.7589377019303717
- Mean Citation Score: 385.46893
- Max Citation Score: 588.6805400000002
- Similarity Product: 450.6533799529888

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test